|
Evofem Biosciences Inc (EVFM) |
|
Evofem Biosciences Inc
EVFM's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Evofem Biosciences Inc growth rates, revenue grew
by 46.81 % in IV. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Evofem Biosciences Inc net loss decreased from $-5 millions, to $-3 millions in IV. Quarter 2024,
• More on EVFM's Growth
|
|
Evofem Biosciences Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 4.22 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.04.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.37.
• More on EVFM's Valuation
|
|
|
|
|
Evofem Biosciences Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 4.22 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.04.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.37.
• More on EVFM's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com